Cosmo Pharmaceuticals NV (CMOPF)
96.80
-2.39
(-2.41%)
USD |
OTCM |
May 07, 14:24
Cosmo Pharmaceuticals Research and Development Expense (Annual) : 36.21M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amarin Corp. Plc | 16.82M |
| Jazz Pharmaceuticals Plc | 782.74M |
| Prothena Corp. Plc | 134.85M |
| Iterum Therapeutics Plc | 10.17M |
| GH Research Plc | 38.73M |